Long-Acting HIV ART: Lessons From a Year of Cabenuva : vimar

Cabenuva, the first long-acting injectable drug for HIV treatment, was approved in January and is slowly rolling out to clinics and patients nationwide.

Related Keywords

Glasgow , Glasgow City , United Kingdom , United States , Utrecht , Netherlands , Canada , Lviv , L Vivs Ka Oblast , Ukraine , Ottawa , Ontario , Canadians , Canadian , Annemarie Wensing , Marta Vasylyev , Chloe Orkin , Jonathan Angel , Glaxosmithkline , Gilead Sciences , Drug Administration , Division Of Infectious Diseases , University Of Ottawa , University Medical Center Utrecht , Queen Mary University Of London , Health Canada , Clinical Society , Infectious Diseases , Queen Mary University , Viiv Healthcare , Black African , Indigenous Canadian , Lviv Regional , Parallel Session , Antiretroviral Therapy , Antiretroviral Therapy Art , Art , Atazanavir , Darunavir , Travirine , Ipranavir , Herapy Antiretroviral , Hiv Infection , Shiv , Raids , Acquired Immune Deficiency Syndrome , Fatigue , Injectable Medications , , Viral Load , Insurance , Health Care Quality Access Evaluation , Nonnucleoside Reverse Transcriptase Inhibitors , Nrtis , Nhibitor Nonnucleoside Reverse Transcriptase , N ,